PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Free cash flow 2016–2018
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.2MFY2018 · since FY2016: -$21.9M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | -$5.2M | — |
| FY2016 | -$21.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PVCT financial trends
PVCT RevenuePVCT Net incomePVCT Net marginPVCT Gross profitPVCT Gross marginPVCT Operating incomePVCT Operating marginPVCT Operating cash flowPVCT Capital expendituresPVCT Return on equityPVCT Stock buybacksPVCT Dividends paidPVCT Total assetsPVCT Total liabilitiesPVCT Shareholders’ equityPVCT overview →